MK-677 Buying Guide for Researchers

Buying MK-677 (ibutamoren) for research work comes down to four verifiable things: analytical data tied to the exact batch you receive, a supplier who publishes that data rather than selling it or withholding it until after checkout, pricing and minimums you can see before you commit, and clear research-use-only terms on every document in the chain. Everything else — slick product photography, rotating discount codes, vague promises about "pharmaceutical grade" material — is noise. If a supplier cannot show you a batch-matched certificate of analysis before you place an order, the evaluation is already over.

This guide is written for business buyers: operators stocking a research catalog, resellers building a brand, and purchasing managers who answer to someone for every line item. All compounds discussed here are for laboratory research use only. Nothing below is dosing guidance, administration guidance, or a treatment protocol, and none of these compounds are FDA-approved drugs.

Why MK-677 behaves differently from the rest of your catalog

MK-677, also known as ibutamoren, is frequently shelved alongside research peptides, but chemically it does not belong there. It is a non-peptide small molecule — a spiropiperidine — that acts as a growth hormone secretagogue receptor agonist, which is the same receptor family the endogenous hormone ghrelin signals through. It was developed as an investigational compound and studied in the context of the growth hormone and IGF-1 axis. Research suggests it raises circulating growth hormone and IGF-1 markers in study models, but it never reached regulatory approval as a therapeutic product, and it should never be represented as one.

That chemistry matters commercially for three reasons. First, the analytical methods used to confirm a lyophilized peptide's identity and purity are not interchangeable with the methods appropriate to a small molecule — the HPLC conditions differ, and mass-spec confirmation is interpreted differently. A supplier who sends you a peptide-template COA with the compound name swapped in has told you something important about their quality system.

Second, presentation differs. Research peptides typically arrive as lyophilized powder in sealed vials. Small molecules in the research market show up in several formats, and format affects stability, shipping tolerance, and how long a stocked lot stays within spec. Ask what form the material ships in and what storage conditions the stability data assumes.

Third, catalog taxonomy and marketing language get sloppy around this compound. Listing MK-677 as a "peptide" is a small inaccuracy, but it is the kind of small inaccuracy that signals a supplier is repackaging rather than sourcing and testing. Precision in a product description is cheap. Suppliers who skip it usually skip costlier things too.

The documents that separate a real supplier from a repackager

The certificate of analysis is the entire negotiation, compressed into one page. A usable COA is tied to a specific batch or lot number, names the compound unambiguously, states the analytical methods used, reports a purity figure with the method that produced it, carries a test date, and identifies who ran the analysis. If any of those elements is missing, the document is decorative.

What should make you walk away:

• A COA with no lot number. It cannot be matched to the vial in your hand, which means it proves nothing about what you received.
• COAs sold separately or released only after purchase. Charging for the evidence that the product is what it claims to be inverts the relationship. Test data is a cost of doing business, not an upsell.
• Image-only PDFs with no lab letterhead or contact details. If you cannot independently reach the lab that signed it, you cannot verify it.
• A single COA reused across every batch for months. Purity is a property of a batch, not of a brand.
• Purity stated without a method. "99% pure" means nothing until you know whether that came from HPLC, and at what wavelength and gradient.

The practical test is simple: ask a prospective supplier to send the COA for the lot currently in stock, before you spend anything. A supplier with real testing infrastructure answers that in a sentence. A repackager stalls, redirects to a generic spec sheet, or explains why the batch document is confidential.

Supplier evaluation at a glance

How wholesale pricing and minimums actually work

Research-compound wholesale pricing is built in tiers, and the tiers are driven by things that have nothing to do with how friendly the sales rep is. Synthesis or manufacturing complexity sets the floor. Raw material cost moves with the market. Testing cadence — how often a supplier pulls samples and how broad the panel is — is a real line item that gets absorbed either into the unit price or into the buyer's risk. Fill, labeling, cold-chain handling where relevant, and fulfillment overhead stack on top.

Margins and breakpoints vary widely by volume, compound category, and how a buyer positions the product, so treat any supplier who quotes you a specific margin figure with suspicion. Nobody can forecast your economics from the outside. What a supplier can legitimately give you is a transparent tier structure you can model against your own numbers.

The questions worth asking before the first order:

• Is the tier schedule published, or does it only appear after an application and a phone call?
• Does the quoted unit price include batch testing, or is analysis billed separately?
• What is the minimum order quantity — per compound, or across a blended cart?
• How is pricing handled on reorders? Does a tier reset, roll, or hold for a period?
• What happens to price when a new lot comes in at a different raw-material cost?

Hidden pricing is the single most common friction point in this market. It is not always malicious — some suppliers genuinely segment by account type — but it costs you time and makes comparison shopping nearly impossible. A published structure lets a buyer model landed cost on a spreadsheet in an afternoon instead of sitting through three discovery calls.

Lead time, origin, and continuity of supply

A good price on material you cannot reliably restock is not a good price. Fulfillment origin is the first question: material shipped from overseas introduces customs variability that is outside both your control and your supplier's, and a single held shipment can empty a shelf. Domestic fulfillment shortens the chain and makes lead times something you can actually plan around.

Continuity is the second question, and it is the one most buyers forget until it bites. Ask how often lots are replaced, whether you will be notified when a lot changes, and whether a new COA is issued and published every time. Lot-to-lot consistency is a reasonable expectation from a disciplined supplier and an unreasonable one from a broker who buys opportunistically.

Third, ask the unglamorous operational questions. What is the policy on a damaged or short shipment? Who absorbs the cost of a lot that fails incoming inspection? How are backorders communicated? These answers tell you more about a partner than any purity claim.

Compliance questions to settle before you buy

This section is informational and is not legal advice. Research-use-only compounds sit in a regulatory space that is genuinely unsettled in places, and the answers depend on your jurisdiction, your business model, and facts only your own counsel knows.

The right posture is to treat the following as open questions to resolve with a licensed attorney and, where applicable, your state licensing board — not as points to look up online and assume settled:

• How are research-use-only compounds classified for the activity your business actually conducts, and does that classification change if you resell rather than consume them internally?
• What registrations, permits, or licenses, if any, apply to purchasing, storing, or reselling research chemicals in your jurisdiction?
• What labeling and record-keeping obligations attach to material you resell, and how long must those records be retained?
• What marketing claims are off-limits, and how do advertising rules apply to compound descriptions on your own storefront?
• How should purchase agreements and downstream terms document research-use-only status?

Generally speaking, the common thread across jurisdictions is documentation: who bought what, when, in what quantity, with what supporting analysis. Build that habit before anyone asks for it. And where a specific rule is uncertain, get the answer in writing from counsel rather than from a supplier's FAQ page — including this one.

What Real Peptides does differently

Real Peptides operates a Wholesale Partner Program built around the documentation gaps described above. Every compound is tested to 99%+ HPLC purity, and testing is applied as a seven-panel batch protocol rather than a single purity check. Certificates of analysis are publicly verifiable — a prospective buyer can review the lab results directly, before applying, before ordering, and without paying for the privilege. That is the inverse of the COA-as-upsell practice that still circulates in this market.

Fulfillment is handled from within the United States, with orders shipping in five to seven days, which removes the customs variability that makes overseas sourcing hard to plan around. Onboarding runs through a three-step wholesale application rather than an open-ended sales cycle.

Buyers evaluating growth hormone secretagogue research compounds generally will find adjacent items in the catalog, and the same purity standard and batch-testing protocol apply across the full line rather than to a handful of flagship products. All material is supplied for laboratory research use only and is not sold for human consumption.

If your purchasing process already asks for batch-matched analysis, published pricing, and a stated lead time, the Wholesale Partner Program application is the next step — the diligence you would normally run after signing is largely front-loaded into publicly available documentation, so the application is a formality rather than the beginning of an investigation.

For buyers mapping out a growth hormone secretagogue research category, the catalog includes Ipamorelin 10mg, CJC-1295 No DAC 10mg, and Tesamorelin 10mg, with the broader Growth Factor & Tissue Signaling Research and Popular Peptides collections covering the compounds most wholesale accounts stock first.